Shutdown has Aimmune waiting on FDA on multiple fronts

Shutdown has Aimmune waiting on FDA on multiple fronts

Shutdown has Aimmune waiting on FDA on multiple fronts — a sign of broader delays for biopharma

By ADAM FEUERSTEIN @adamfeuerstein

JANUARY 9, 2019